Action to Control Cardiovascular Risk in Diabetes Trial
Alternate Titles(s): ACCORD
Action to Control Cardiovascular Risk in Diabetes (ACCORD) was a large clinical trial examining methods of lowering the rate of cardiovascular disease in adults with type two diabetes. The study was composed of three main clinical trials: an intensive lowering of blood sugar levels (Glycemia Trial), intensive lowering of blood pressure (Blood Pressure Trial), and treatment of multiple blood lipids with a combination of a fibrate and a statin (Lipid Therapy Trial). There were two ancillary trials: an evaluation of ACCORD interventions on patients with diabetic retinopathy (EYE Substudy) and an evaluation of ACCORD interventions to improve glycemic control on the adverse effects of type 2 diabetes on the brain (MIND Substudy).
The study began in 1999 and recruited at total of 10,251 adults with type 2 diabetes and HbA1c concentrations of at least 7.5%.
- 2001 - 2009
- Geographic Coverage
- Local Expert